ATS/ERS/WASOG statement on sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 2, 1999, Pages 149-173

  Hunninghake, Gary W ^a,b   Costabel, Ulrich ^a   Ando, Masayuki ^a   Baughman, Robert ^a   Cordier, Jean François ^a   Du Bois, Ronald ^a   Eklund, Anders ^a   Kitaichi, Masanori ^a   Lynch, Joseph ^a   Rizzato, Gianfranco ^a   Rose, Cecil ^a   Selroos, Olof ^a   Semenzato, Gianpietro ^a   Sharma, Om P ^a  

^a College of Medicine ^*

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFLAZACORT; HYDROXYCHLOROQUINE; ITRACONAZOLE; KETOCONAZOLE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VITAMIN D;

BRONCHIECTASIS; CLINICAL FEATURE; DRUG CARCINOGENICITY; GENETICS; HEMATOLOGIC DISEASE; HISTORY OF MEDICINE; HUMAN; HYPERCALCEMIA; IMMUNOLOGY; INCIDENCE; MUCOSA INFLAMMATION; MUSCULOSKELETAL DISEASE; NAUSEA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SARCOIDOSIS; TERATOGENICITY; VOMITING;

ADRENAL CORTEX HORMONES; ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; PROGNOSIS; SARCOIDOSIS;

EID: 0032881310     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (332)

1. Yamamoto M, Sharma OP, Hosoda Y: Special Report: The 1991 Descriptive Definition of Sarcoidosis. Sarcoidosis 1992; 9: 33-34.
2. James DG Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med 1997; 18: 663-679.
3. Hosoda Y, Odaka M: History of sardoidosis. Semin Respir Med 1992; 13: 359-367.
4. Hutchinson J: Case of livid papillary psoriasis. Illustrations of Clinical Surgery. vol. 1. J & A Churchill, Londres. 1877; pp 42-43.
5. Hutchinson J: On eruptions which occur in connection with gout. Case of Mortimer's malady. Arch Surg 1898; 9: 307-314.
6. Boeck C: Multiple benign hud-sarkoid. Norsck Laegevidensk 1899; 60: 1321.
7. Boeck C: Multiple benign sarkoid of the skin. J Cutan Genitourinary Dis. 1899; 17: 543-550.
8. Besnier M: Lupus pernio de la face: synovites fungueuses (scrofulo-tuberculeuses) symétriques des extremités supérièures. Ann Dermatol Syphiligr 1899; 10: 33-36.
9. Tenneson M: Lupus pernio (Lupus pernio). Bull Soc Fr Dermatol Syphiligr 1892; 3: 417-419.
10. Kreibich K: Ueber lupus pernio. Arch Derm Syph (Wien) 1904; 71: 13-16.
11. Jüngling O: Ostitits tuberculosa multiplex cystica. Fortschr Geb Roentgenstr 1920; 27: 375-383.
12. Heerfordt C: Uber eine Febris uveo-parotidea subchronica. Von Graefe's Archiv fur Opthalmologie 1909; 70: 254-273.
13. Kuznitsky E, Bittorf A: Sarkoid mit Beteiligung innerer Organe. Münch Med Wochensch 1915; 1349-1353.
14. Schaumann J: Etude sur le lupus pernio et ses rapports avec les sarcoides et la tuberculose. Ann Dermatol Syphiligr 1916-1917; 357-363.
15. Schaumann J: Etude anatomo pathologue et histologique sur les localisations viscerales de la lymphogranulomatose benigne. Bull Soc Fr Dermatol Syphiligr 1934; 1167-1322.
16. Harrell G, Fisher S: Blood chemical changes in Boeck's sarcoid with particular reference to protein, calcium, and phosphatase values. J Clin Invest 1939; 18: 687-693.
17. Kveim A: En ny og spesifikk kutan-reaksjon ved Boecks sarcoid. Nord Med 1941; 9: 169-172.
18. Williams R, Nickerson D: Skin reactions in sarcoid. Proc. Soc Exp Biol Med 1935; 33:403-405.
19. Siltzbach L: The Kveim test in sarcoidosis: a study of 750 patients. JAMA 1961; 178: 476-482.
20. Löfgren S: Erythema nodosum. Studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946; 124: 1-197.
21. Löfgren S: Primary pulmonary sarcoidosis. Acta Med Scand 1946; 145: 424-455.
22. Longscope W, Frieman D. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 31: 1-142.
23. Maycock RI, Bertrand P, Morrison CE, Scott JH: Manifestations of sarcoidosis: Analysis of 145 patients with review of nine series selected from the literature. Am J Med 1963; 35: 67-89.
24. Scadding J: Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after 5 years' observations. Br Med J 1961; 2: 1165-1172.
25. Siltzbach L: Sarcoidosis: clinical features and management. Med Clin North Am 1967; 51:483-502.
26. Siltzbach LE, James DG, Neville E et al: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847-852.
27. James DG, Neville E, Siltzbach LE: A worldwide review of sarcoidosis. Ann NY Acad Sci 1976; 278: 321-334.
28. Israel H, Sones M: Sarcoidosis. Clinical observation on 161 cases. Ann Intern Med 1958; 102: 766-775.
29. Neville E, Walker AN, James DG: Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983; 52: 525-533.
30. Romer FK: Presentation of sarcoidosis and outcome of pulmonary changes. Dan Bull Med 1982; 29: 27-32.
31. Hillerdal G, Nou E, Osterman K, Schmekel B: Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32.
32. Sones M, Israel HL, Dratman MB, Frank JH: Effect of cortisone in sarcoidosis. N Engl J Med 1951; 244: 209-213.
33. Siltzbach LE: Effects of cortisone in sarcoidosis: a study of 13 patients. Am J Med 1952; 12: 139-160.
34. Smellie H, Apthorp GH, Marshal R: The effect of corticosteroid treatment on pulmonary function in sarcoidosis. Thorax 1961; 16: 87-90.
35. Sharma OP, Colp C, Williams MH Jr: Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies. Am J Med 1966; 41: 541-551.
36. Johns CJ, Zachary JB, Ball WC jr: A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med J 1974; 134: 271-283.
37. Johns CJ, Schonfeld SA, Scott PP, Zachary JB, MacGregor MI: Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. Ann NY Acad Sci 1986; 465: 702-712.
38. Emergil C, Sobol BJ, Williams MH: Long-term study of pulmonary sarcoidosis: the effects of steroid therapy as evaluated by pulmonary function studies. J Chronic Dis 1969; 22: 69-86.
39. Wurm K, Reindell H, Heilmeyer L: Der Lungenboeck in Röntgenbild. In Editor Ed. Eds. Thieme, Stuttgart. 1958.
40. Eule H, Weinecke A, Roth I, Wuthe H: The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study. Ann NY Acad Sci 1986; 465:695-701.
41. Israel HL, Fouts DW, Beggs RA: A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 1973; 107: 609-614.
42. Selroos O, Sellergren TL: Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis 1979; 60: 215-221.
43. Yamamoto M, Saito N, Tachibana T: Effects of an 18 month corticosteroid therapy to stage I and stage II sarcoidosis patients (control trial). In Chrétien J, Marsac J, Saltiel J Eds. Sarcoidosis and Other Granulomatous Disorders. Pergamon Press, Paris. 1980; pp 470-474.
44. Young RL, Harkleroad LE, Lordon RE, Weg JG: Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med 1970; 73: 207-212.
45. Zaki MH, Lyons HA, Leilop L, Huang CT: Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study. N.Y. State J Med 1987; 87: 496-499.
46. Gibson GJ, Prescott RJ, Muers MF, Middleton WG et al: British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment [see comments]. Thorax 1996; 51:238-247.
47. James DG, Carstairs LS, Trowell J, Sharma OP: Treatment of sarcoidosis. Report of a controlled therapeutic trial. Lancet 1967; 2: 526-528.
48. Koerner SK, Sakowitz AJ, Appelman RI, Becker NH, Schoenbaum SW: Transbronchial lung biopsy for the diagnosis of sarcoidosis. N Engl J Med 1975; 293: 268-270.
49. Koontz CH, Lee RJ, Nelson RA: Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 1976; 85: 64-66.
50. Roethe RA, Fuller PB, Byrd RB, Hafermann DR: Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest 1980; 77: 400-402.
51. Hunninghake GW, Crystal RG: Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-434.
52. Thomas PD, Hunninghake GW: Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987: 135: 747-760.
53. James DG, Neville E, Walker A: Immunology of sarcoidosis. Am J Med 1975; 59: 388-394.
54. Lieberman J: Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365-372.
55. Crystal RG, Roberts RC, Hunninghake GW, Gadek JE, Fulmer JD, Line BR: Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med 1931; 94: 73-94.
56. Daniele RP, Dauber JH, Rossman MD: Immunologic abnormalities in sarcoidosis. Ann Intern Med 1980; 92: 406-416.
57. Line BR, Hunninghake GW, Keogh BA, Jones AE Johnston GS, Crystal RG: Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis 1981; 123: 440-446.
58. Hennessy TW, Ballard DJ, DeRemee RA, Chu CP, Melton LJ: The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935-1984. J Clin Epidemiol 1988; 41: 565-570.
59. Gordis L: Sarcoidosis. Epidemiology of Chronic Lung Diseases in Children. The John Hopkins University Press, Baltimore. 1973; pp 53-78.
60. Alsbirk PH: Epidemiologic studies on sarcoidosis in Denmark based on a nation-wide central register. A preliminary report. Acta Med Scand 1964; 176:106-109.
61. Iwai K, Sekiguchi M, Hosoda Y et al: Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994; 11: 26-31.
62. Milman N, Selroos O: Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990; 7: 50-57.
63. Henke CE, Henke G, Elveback LR, Beard CM, Bollard DJ, Kurland LT: The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986; 123: 840-845.
64. Rybicki BA, Major M, Popovich Y, Jr, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
65. Bresnitz EA, Strom BL: Epidemiology of sarcoidosis. Epidemiol Rev 1983; 5: 124-156.
66. James DG: Sarcoidosis and Other Granulmatous Disorders. Marcel Dekker, Inc, New York 1994.
67. Mañá J, Badrinas F, Morera J, Fité E, Manresa F, Fernandez-Nogues F: Sarcoidosis in Spain. Sarcoidosis 1992; 9: 118-122.
68. Keller AZ: Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971; 94: 222-230.
69. Mitchell DN, Scadding JG: Sarcoidosis. Am Rev Respir Dis 1974; 110: 774-802.
70. McNicol MW, Luce PJ: Sarcoidosis in a racially mixed community. J R Coll Physicians Lend 1985: 19: 179-183.
71. Edmondstone WM, Wilson AG: Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 1985; 79: 27-36.
72. Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O: The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 159-166.
73. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y: Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993; 43: 372-376.
74. Iwai K, Takemura T, Kitaichi M, Kawabata Y, Matsui Y: Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn 1993; 43: 377-385.
75. Gideon NM, Mannino DM: Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med 1996; 100: 423-427.
76. Parkes SA, Baker SB, Bourdillon RE, Murray CR, Rakshit M: Epidemiology of sarcoidosis in the Isle of Man - 1: A case controlled study. Thorax 1987; 42: 420-426.
77. Hills SE, Parkes SA, Baker SB: Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space-time clustering. Thorax 1987: 42: 427-430.
78. Bardinas F, Morera J, Fité E, Plasencia A: Seasonal clustering of sarcoidosis [letter]. Lancet 1989; 2: 455-456.
79. Glennas A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B, Thoen JE: Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995; 34: 45-50.
80. Gentry JT, Nitowsky HM, Michael M: Studies on the epidemiology of sarcoidosis in the United States: The relationship to soil areas and to urban-rural residence. J Clin Invest 1955; 34: 1839-1856.
81. Cummings MM, Dunner E, William JH: Epidemiologic and clinical observations in sarcoidosis. Ann Intern Med 1959: 50: 879-890.
82. Comstock GW, Keltz H, Spencer DJ: Clay eating and sarcoidosis: A controlled study in the state of Georgia. Am Rev Respir Dis 1961; 84: S130-S134.
83. Buck AA: Epidemiologic investigations of sarcoidosis: I. Introduction-material and methods. Am J Hyg 1961; 74: 137-151.
84. Buck AA, Sartwell PE: Epidemiologic investigations of sarcoidosis: II. Skin sensitivity and environmental factors. Am J Hyg 1961; 74: 152-173.
85. Buck AA, McKusick VA: Epidemiologic investigations of sarcoidosis: III. Serum proteins; syphilis; association with tuberculosis; familial aggregation. Am J Hyg 1961; 74: 174-188.
86. Buck AA: Epidemiologic investigations of sarcoidosis: IV. Discussion and summary. Am J Hyg 1961; 74: 189-202.
87. Horwitz O: Geographic epidemiology of sarcoidosis in Denmark. Am Rev Respir Dis 1961; 84: 5135-5142.
88. Douglas AC: Sarcoidosis in Scotland. Am Rev Respir Dis 1961; 84: S143-S147.
89. Redline S, Bama BP, Tomashefski JF, Jr, Abraham JL: Granulomatous disease associated with pulmonary deposition of titanium. Br J Ind Med 1986; 43: 652-656.
90. De Vuyst P, Dumortier P, Schandene L, Estenne M, Verhest A, Yernault JC: Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987; 135: 493-497.
91. Skelton HGd, Smith KJ, Johnson FB, Cooper CR, Tyler WF, Lupton GP: Zirconium granuloma resulting from an aluminum zirconium complex: a previously unrecognized agent in the development of hypersensitivity granulomas. J Am Acad Dermatol 1993; 28: 874-876.
92. Parkes SA, Baker SB, Bourdillon RE et al: Incidence of sarcoidosis in the Isle of Man. Thorax 1985; 40: 284-287.
93. Bresnitz EA, Stolley PD, Israel HL, Soper K: Possible risk factors for sarcoidosis. A case-control study. Ann NY Acad Sci 1986; 465: 632-642.
94. Edmondstone WM: Sarcoidosis in nurses: is there an association? Thorax 1988; 43: 342-343.
95. Kern DG, Neill MA, Wrenn DS, Varone JC: Investigation of a unique time-space cluster of sarcoidosis in firelighters. Am Rev Respir Dis 1993: 148: 974-980.
96. Sarcoidosis among U.S. Navy enlisted men, 1965-1993. MMWR 1997; 46: 539-543.
97. Douglas JG, Middleton WG, Gaddie J et al: Sarcoidosis: a disorder commoner in nonsmokers? Thorax 1986; 41: 787-791.
98. Revsbech P: Is sarcoidosis related to exposure to pets or the housing conditions? A case-referent study. Sarcoidosis 1992; 9: 101-103.
99. Valeyre D, Soler P, Clerici C et al: Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988; 43: 516-524.
100. Harrington DW, Major M, Rybicki B, Popovich J, Maliarik M, Iannuzzi MC: Familial sarcoidosis: Analysis of 91 families. Sarcoidosis 1994; 11: 240-243.
101. Brennan NJ, Crean P, Long JP, Fitzgerald MX: High prevalence of familial sarcoidosis in an Irish population. Thorax 1984; 39: 14-18.
102. Hiraga Y, Hosoda Y, Zenda I: A local outbreak of sarcoidosis in Northern Japan. Z Erkr Atmungsorgane 1977; 149: 38-43.
103. Pasturenzi L, Martinctti M, Cuccia M, Cipriani A, Semenzato G, Luisetti M: HLA class I, U, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group. Chest 1993; 104: 1170-1175.
104. Gardner J, Kennedy HG, Hamblin A, Jones E: HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984; 39: 19-22.
105. Lenhart K., Kolek V, Bartova A: HLA antigens associated with sarcoidosis. Dis Markers 1990; 8: 23-29.
106. Heyll A, Meckenstock G, Aul C et al: Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 161-164.
107. Semenzato G, Pezzutto A. Chilosi M, Pizzolo G: Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis [letter]. N Engl J Med 1982; 306: 48-49.
108. Konishi K, Moller DR, Saltini C, Kirby M, Crystal RG: Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest 1988; 82: 775-781.
109. Robinson RBW, McLemore TL, Crystal RG: Gamma interferon is spontaneously released by alveolary macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1988; 75: 1488-1505.
110. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE: Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990; 115: 36-42.
111. Moller DR, Forman JD, Liu MC et al: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; 156: 4952-4960.
112. Agostini C, Trentin L, Facco M et al: Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996: 157: 910-918.
113. Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG: Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 1988; 82: 1183-1191.
114. Grunewald J, Olerup O, Persson U, Ohm MB, Wigzell U, Eklund A: T-cell receptor variable region gene usage by CD4+ and CD8t T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91: 4965-4969.
115. Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR: Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J Clin Invest 1994; 94: 1533-1542.
116. Trentin L, Zambello R, Facco M et al: Selection of T lymphocytes bearing limited TCR-Vbeta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. Am J Respir Crit Care Med 1997; 155: 587-596.
117. Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H: Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1995; 1: 287-296.
118. DuBois RM, Kirby M, Balbi B, Saltini C, Crystal RG: T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of T-cell antigen receptor Am Rev Respir Dis 1983; 145: 1205-1211.
119. Semenzato G: Bias toward use of T-cell receptor variable regions in the lung: research tool or clinically useful technique? Eur Respir J 1997; 10: 767-769.
120. Perez RL, Roman J, Staton GW, Jr, Hunter RL: Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate. Am J Respir Crit Care Med 1994; 149: 510-518.
121. Martinetti M, Tinelli C, Kolek V et al: "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152: 557-564.
122. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J: HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-1605.
123. Kunikane H, Abe S, Yamaguchi E et al: Analysis of restriction fragment length polymorphism for lhe HLA-DR gene in Japanese patients with sarcoidosis. Thorax 1994; 49: 573-576.
124. Abe S, Yamaguchi E, Makimura S, Okazaki N, Kunikane H, Kawakami Y: Association of HLA-DR with sarcoidosis. Correlation with clinical course. Chest 1987; 92: 488-490.
125. Mitchell DN, Rees RJ: A transmissible agent from sarcoid tissue. Lancet 1969; 2: 81-84.
126. Newman LS: Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 1995; 12: 7-19.
127. Mangiapan G, Hance AJ: Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995; 12: 20-37.
128. Milman N, Andersen AB: Detection of antibodies in serum against M. tuberculosis using western blot technique. Comparison between sarcoidosis patients and healthy subjects. Sarcoidosis 1993; 10: 29-31.
129. Chapman JS, Speight M: Further studies of mycobacterial antibodies in the sera of sarcoidosis patients. Acta Med Scand Suppl 1964; 425: 61-67.
130. Hanngren A, Odham G, Eklund A, Hoffner S, Stjernberg N, Westerdahl G: Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 1987; 4: 101-104.
131. Eishi Y, Ando N, Takemura T, Matui Y: Pathogenesis of granuloma formation in lymph nodes with sarcoidosis. Sarcoidosis 1992; 9 (Supplement 1): 669.
132. Almenoff PL, Johnson A, Lesser M, Mattman LH: Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-533.
133. Saboor SA, Johnson NM, McFadden J: Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-1015.
134. Mitchell IC, Turk JL, Mitchell DN: Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation [see comments]. Lancet 1992; 339: 1015-1017.
135. Agostini C, Trentin L, Zambello R et al: CDS alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. Am J Med 1993; 95: 466-472.
136. Kreipe H, Radzun HJ, Heidorn K et al: Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis. Lab Invest 1990; 62: 697-703.
137. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA; Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 235-244.
138. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA: Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med 1984; 310: 154-166.
139. Semenzato G, Agostint C. (In Press). Immunologic development of interstitial lung disease: the paradigm of sarcoidosis. In Schwarz MI and King TE, Jr Eds. Interstitial Lung Disease, 3rd ed. Marcel Dekker, Inc., Ontario, Canada.
140. Agostini C, Zambello R, Sancetta R et al: Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996; 153: 1359-1367.
141. Devergne O, Marfaing-Koka A, Schall TJ et al: Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells [published erratum appears in J Exp Med 1994 Aug 1;180(2):775]. J Exp Med 1994; 179: 1689-1694.
142. Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ: T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 1996; 97: 1931-1941.
143. Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG: Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset J Clin Invest 1986; 77: 1962-1970.
144. Semenzato G, Agostini C, Trentin L et al: Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients. Clin Exp Immunol 1984; 57: 331-337.
145. Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308: 793-800.
146. Hunninghake GW, Bedell GN, Zavala DC, Monick M, Brady M: Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 634-638.
147. Kunkel SL, Lukacs NW, Strieter RM, Chensue SW; Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 120-128.
148. Kitaichi M: Pathology of pulmonary sarcoidosis. Clin Dermatol 1986; 4: 108-115.
149. Rosen Y: Sarcoidosis. In Dail DH, and Hammer SP Eds. Pulmonary Pathology, 2nd ed. Springer-Verlag, New York. 1994; pp 13-645.
150. Sheffield EA, Williams WJ:Pathology. In James DG Ed. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, Inc., New York. 1994; pp 45-67.
151. Colby TV: Interstitial lung diseases. In Thurlbeck W, and Churg A Eds. Pathology of the Lung, 2nd ed. Thieme Med Publishers, New York. 1995; pp 589-737.
152. Churg A, Carrington CB, Gupta R: Necrotizing sarcoid granulomatosis. Chest 1979; 76: 406-413.
153. Perry A, Vuitch F: Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995; 119: 167-172.
154. Lacronique JC, Bernaudin J, Loler Pét al: Alveolitis and granulomas: sequential course in pulmonary sarcoidosis. In Chretien J, Marsac J, and Saltiel J Eds. Sarcoidosis and Other Granulomatous Disorders. Pergamon Press, Paris. 1983; pp 36-42.
155. Takemura T, Matsui Y, Saiki S, Mikami R: Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol 1992; 23: 1216-1223.
156. Tuder RM: A pathologist's approach to interstitial lung disease. Curr Opin Pulm Med 1996; 2: 357-363.
157. Freiman DG, Hardy HL: Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol 1970; 1: 25-44.
158. Woodard BH, Rosenberg SI, Farnham R, Adams DO: Incidence and nature of primary granulomatous inflammation in surgically removed material. Am J Surg Pathol 1982; 6: 119-129.
159. Miettinen M: Histological differential diagnosis between lymph node toxoplasmosis and other benign lymph node hyperplasias. Histopathology 1981; 5: 205-216.
160. Benjamin DR: Granulomatous lymphadenitis in children. Arch Pathol Lab Med 1987; 111: 750-753.
161. Symmans PJ, Brady K, Keen CE: Calcium oxalate crystal deposition in epithelioid histiocytes of granulomatous lymphadenitis: analysis by light and electronmicroscopy. Histopathology 1995; 27: 423-429.
162. Schnitzer B: Reactive lymphoid hyperpalsias. In Jaffe E Ed. Surgical Pathology of Lymph Nodes and Related Organs, 2nd ed. WB Saunders Co., Philadelphia. 1995; pp 98-132.
163. Mehregan A, Hashimoto K, Mehregan D, Mehregan D: Granulomatous inflammation and proliferation. Pinkus' Guide to Dermatohistopathology, 6th ed. Prentice-Hall International, Inc., London. 1995; pp 295-371.
164. Harrington PT, Gutierrez JJ, Ramirez-Ronda CH, Quinones-Soto R, Bermudez RH, Chaffey J: Granulomatous hepatitis. Rev Infect Dis 1982; 4: 638-655.
165. Satti MB, al-Freihi H, Ibrahim EM et al: Hepatic granuloma in Saudi Arabia: a clinicopathological study of 59 cases. Am J Gastroenterol 1990; 85: 669-674.
166. Bodem CR, Hamory BH, Taylor HM, Kleopfer L: Granulomatous bone marrow disease. A review of the literature and clinicopathologic analysis of 58 cases. Medicine 1983; 62: 372-383.
167. Neiman RS: Incidence and importance of splenic sarcoid-like granulomas. Arch Pathol Lab Med 1977; 101: 518-521.
168. Brincker H: Sarcoid reactions in malignant tumors. Cancer Treat Rev 1986; 13: 147-156.
169. Romer F: Sarcoidosis and Cancer. In James DG Ed. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, Inc. New York 1994; pp 401-415.
170. Pickard WR, Clark AH, Abel BJ: Florid granulomatous reaction in a seminoma. Postgrad Med J 1983; 59: 334-335.
171. Dietl J, Horny HP, Ruck P, Kaiserling E: Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells. Cancer 1993; 71: 2562-2568.
172. Brincker H: Granulomatous lesions of unknown significance: the GLUS syndrome. In James DG Ed. Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, Inc, New York 1994; pp 69-86.
173. Brincker H, Pedersen NT: Immunohistologic separation of B-cell-positive granulomas from B-cell-negative granulomas in paraffin-embedded tissues with special reference to tumor-related sarcoid reactions. Apmis 1991; 99: 282-290.
174. Teirstein AS, Padilla ML, De Palo LR, Schilero GJ: Sarcoidosis mythology. Mt Sinai J Med 1996; 63: 335-341.
175. Nagai S, Izumi T: Pulmonary sarcoidosis: population differences and pathophysiology. South Med J 1995; 88: 1001-1010.
176. Lynch JP 3rd, Sharma OP, Baughman RP: Extrapulmonary sarcoidosis [In Process Citation]. Semin Respir Infect 1998; 13: 229-254.
177. Telenti A, Hermans PE: Idiopathic granulomatosis manifesting as fever of unknown origin. Mayo Clin Proc 1989; 64: 44-50.
178. Hendrick DJ, Blackwood RA, Black JM: Chest pain in the presentation of sarcoidosis. Br J Dis Chest 1976; 70: 206-210.
179. Bechtel JJ, Starr TD, Dantzker DR. Bower JS: Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981; 124: 759-761.
180. Lynch JP 3rd, Kazerconi EA, Gay SE: Pulmonary sarcoidosis. Clin Chest Med 1997; 18: 755-785.
181. Salazar A, Mañ́ J. Corbella X, Albareda JM, Pujol R: Splenomegaly in sarcoidosis: a report of 16 cases. Sarcoidosis 1995; 12: 131-134.
182. Fahy GJ, Marwick T, McCrcery CJ, Quigley PJ, Maurer BJ: Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 1996; 109: 62-66.
183. Kinney EL, Caldwell JW: Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 1990: 41: 573-576.
184. Maddrey WC, Johns CJ, Boitnon JK, Iber FL: Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine 1970; 49: 375-395.
185. Siltzbach LE: In Rovinsky JJ, and Guttmacker AFC Eds. Medical, Surgical and Gynecologic Complications of Pregnancy. William & Wilkins, Baltimore. 1965; p 150.
186. Devaney K, Goodman ZD, Epstein MS, Zimmerman HJ, Ishak KG: Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993; 17: 1272-1280.
187. Lower EE, Smith JT, Martelo OJ, Baughman RP: The anemia of sarcoidosis. Sarcoidosis 1988; 5: 51-55.
188. Valla D, Pessegueiro-Miranda H, Degott C, Lebrec D, Rueff B, Benhamou JP: Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 1987; 63: 531-544.
189. Vatti R, Sharma OP: Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 73-76.
190. Sharma OP: Cutaneous sarcoidosis: clinical features and management. Chest 1972; 61: 320-325.
191. James D: Sarcoidosis of the skin. Semin Respir Med 1992; 13: 422-441.
192. Karma A: Ophthalmic changes in sarcoidosis. Acta Ophthalmol Suppl 1979; 141: 1-94.
193. Oksanen VE: Neurosarcoidosis. In James DG Ed. Sarcoidosis and Other Granulomatous Disorders. vol. 73. Marcel, Kekker Inc., New York. 1994; pp 285-309.
194. Chapelon C, Ziza JM, Piette JC et al: Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990; 69: 261-276.
195. Sharma OP: Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997; 112: 220-228.
196. Williams DWd, Elster AD, Kramer SI: Neurosarcoidosis: gadolinium-enhanced MR imaging. J Comput Assist Tomogr 1990; 14: 704-707.
197. Gran JT, Bohmer E: Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature. Scand J Rheumatol 1996; 25: 70-73.
198. Garcia C, Kumar V, Sharma OP: Pancreatic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 28-32.
199. Sharma OP, Kadakia J, Sharma O: Gastrointestinal Sarcoidosis. Semin Resp Med 1992; 13: 442-449.
200. Browne PM, Sharma OP. Salkin D: Bone marrow sarcoidosis. JAMA 1978; 240: 2654-2655.
201. Goldstein RA, Israel HL, Becker KL, Moore CF: The infrequency of hypercalcemia in sarcoidosis. Am J Med 1971; 51: 21-30.
202. Sharma OP: Vitamin D, calcium, and sarcoidosis. Chest 1996; 109: 535-539.
203. Rizzato G, Colombo P: Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 167-172.
204. Papadopoulos KI, Hornblad Y, Liljebladh H, Hallengren B: High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur J Endocrinol 1996; 134: 331-336.
205. Carmody JP, Sharma OP: Intrascrotal sarcoidosis: case reports and review. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 129-134.
206. Sato A: Renal dysfunction in patients with sarcoidosis. Intern Med 1996; 35: 523-524.
207. Cruzado JM, Poveda R, Mañ́ J et al: Interstitial nephritis in sarcoidosis: simultaneous multiorgan involvement. Am J Kidney Dis 1995; 26: 947-951.
208. Kendig EL Jr. The clinical picture of sarcoidosis in children. Pediatrics 1974; 54: 289-292.
209. James DG, Kendig EL Jr. Childhood sarcoidosis. Sarcoidosis 1988; 5: 57-59.
210. Given FR, DiBendetto RL: Sarcoidosis and Pregnancy Obstet Gynecol 1963; 22: 355.
211. Stadnyk AN, Rubinstein I, Grossman RF et al: Clinical features of sarcoidosis in elderly patients. Sarcoidosis 1988; 5: 121-123.
212. Conant EF, Gliekstein MF, Mahar P, Miller WT: Pulmonary sarcoidosis in the older patient: conventional radiographic features. Radiology 1988; 169: 315-319.
213. Gilman MJ, Wang KP: Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 721-724.
214. Costabel U: Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9 (Suppl. 1): 211-214.
215. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC: Bronchoalveolar lavase cell populations in the diagnosis of sarcoidosis. Chest 1993; 104: 352-361.
216. Bjermer L, Thunell M, Rosenhall L, Stjernberg N: Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85: 229-234.
217. Stjernberg N, Bjornstad-Pettersen H, Truedsson H: Flexible fiberoptic bronchoscopy in sarcoidosis. Acta Med Scand 1980; 208: 397-399.
218. Armstrong JR, Radke JR, Kvale PA, Eichenhorn MS, Popovich J, Jr.: Endoscopic findings in sarcoidosis. Characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann Otol Rhinol Laryngol 1981; 90: 339-343.
219. Israel HL, Albertine KH, Park CH, Patrick H: Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144: 1182-1186.
220. Rizzato G, Blasi A: A European survey on the usefulness of 67Ga lung scans in assessing sarcoidosis. Experience in 14 research centers in seven different countries. Ann NY Acad Sci 1986; 465: 463-478.
221. Raghu G: Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med 1995; 151: 909-914.
222. Gossot D, Toledo L, Fritsch S, Celerier M: Mediastinoscopy vs thoracoscopy for mediastinal biopsy. Results of a prospective nonrandomized study. Chest 1996; 110: 1328-1331.
223. Hiraga Y, Hosoda Y: Acceptability of epidemiologiccal diagnostic criteria for sarcoidosis without histological confirmation. In Mikami R, Hosoda Y, Eds. Sarcoidosis. University of Tokyo Press, Tokyo. 1981; pp 373-377.
224. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ: Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31: 1909-1914.
225. Siltzbach L, Ehrlich J: The Nickerson-Kveim reaction in sarcoidosis. Am J Med 1954; 16: 790-803.
226. James DG: Sarcoidosis today. Sarcoidosis 1991; 8: 163-165.
227. Allen RK: A review of angiotensin converting enzyme in health and disease. Sarcoidosis 1991; 8: 95-100.
228. Keogh BA, Hunninghake GW, Line BR, Crystal RG: The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis 1983; 128: 256-265.
229. Costabel U, Bross KJ, Guzman J, Nilles A, Ruhle KH, Matthys H: Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann NY Acad Sci 1986; 465: 418-426.
230. Hunninghake GW, Gilbert S, Pueringer R et al: Outcome of the treatment for sarcoidosis [see comments]. Am J Respir Crit Care Med 1994; 149: 893-898.
231. Wells A: High resolution computed tomography in sarcoidosis: a clinical perspective [In Process Citation]. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 140-146.
232. Costabel U, du Bois R, Eklund A: Consensus conference: Activity of sarcoidosis. Sarcoidosis 1994; 11: 27-33.
233. Semenzato G: Assessment of disease activity in sarcoidosis: deeds and misdeeds [editorial]. Sarcoidosis 1993; 10: 100-103.
234. Sharma OP: Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 1993; 147: 1598-1600.
235. Reich JM, Johnson RE: Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med 1985; 78: 61-67.
236. Takada K, Ina H, Noda M, Sato T, Yamamoto M, Morishita M: The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol 1993: 46: 359-366.
237. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J: Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997; 156: 1586-1592.
238. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H: Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-631.
239. Viskum K, Vestbo J: Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993; 6: 349-353.
240. Vestbo J, Viskum K: Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994; 11: 123-125.
241. Huang CT, Heurich AE, Sutton AL, Lyons HA: Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981; 62: 231-238.
242. Baughman RP, Winget DB, Bowen EH, Lower EE: Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:154-158.
243. Israel HL, Karlin P, Menduke H, DeLisser OG: Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann NY Acad Sci 1986; 465: 609-618.
244. Newman LS, Rose CS, Maier LA: Sarcoidosis [published erratum appears in N Engl J Med 1997 Jul 10; 337 (2): 139]. N Engl J Med 1997; 336: 1224-1234.
245. Honeybourne D: Ethnic differences in the clinical features of sarcoidosis in South-East London. Br J Dis Chest 1980; 74: 63-69.
246. Ina Y, Takada K, Yamamoto M, Morishita M, Senda Y, Torii Y: HLA and sarcoidosis in the Japanese. Chest 1989; 95: 1257-1261.
247. Smith MJ, Turton CW, Mitchell DN, Turner-Warwick M, Morris LM, Lawler SD: Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 1981; 36: 296-298.
248. Kunikane H, Abe S, Tsuneta Y et al: Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987; 135: 688-691.
249. Raphael SA, Blau EB, Zhang WH, Hsu SH: Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis. Am J Dis Child 1993; 147: 842-848.
250. Rizzato G, Montemurro L: The locomotor system. In James DG Ed. Sarcoidosis and other Granulomatous Disorders. Marcel Dekker, New York. 1994; pp 349-373.
251. Ward K, O'Connor C, Odium C, Fitzgerald MX: Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989; 44: 6-12.
252. Löfgren S: The concept of erythema nodosum revised. Scand J Respir Dis 1967; 48: 465-474.
253. Adams J: Hypercacemia and hypercalcuria. Semin Resp Med 1992; 13: 402-410.
254. Rizzato G, Fraioli P, Montemurro L: Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 1995; 50: 555-559.
255. Johnson D, Yamakido M, Sharma O: Musculoskeletal involvement in sarcoidosis. Semin Respir Med 1992; 13: 415-419.
256. Rohatgi P: Osseous sarcoidosis. Semin Respir Med 1992; 13: 468-488.
257. Sartoris DJ, Resnick D, Resnik C, Yaghmai I: Musculoskeletal manifestations of sarcoidosis. Semin Roentgenol 1985; 20: 376-386.
258. Scott TF: Neurosarcoidosis: progress and clinical aspects. Neurology 1993; 43: 8-12.
259. Agbogu BN, Stern BJ, Sewell C, Yang G: Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52: 875-879.
260. Baughman R, Lower E, Lynch J: Treatment modalities for sarcoidosis. Clin Pulm Med 1994; 1: 223-231.
261. Lynch JP III, McCune WJ: Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997; 155: 395-420.
262. Baughman RP, Shipley R, Eisentrout CE: Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis. Lung 1987; 165: 371-377.
263. Hosoda Y, Mikami R: International controlled clinical trial of prednisone therapy in pulmonary sarcoidosis. Ann NY Acad Sci 1986; 465: 692-694.
264. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE: Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy. Chest 1982; 82: 84-87.
265. Erkkila S, Froseth B, Hellstrom PE et al: Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. Sarcoidosis 1988; 5: 106-110.
266. Pietinalho A, Lindholm A, Haahtela T, Tukiainen P, Selroos O: Inhaled budesonide for treatment of pulmonary sarcoidosis. Results of a double-blind, placebo-controlled, multicentre study Eur Respir J 1996: 9: 406s.
267. Selroos O: Inhaled corticosteroids and pulmonary sarcoidosis. Sarcoidosis 1988; 5: 104-105.
268. Spiteri MA, Newman SP, Clarke SW, Poulter LW: Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir J 1989; 2: 218-224.
269. Zych D, Pawlicka L, Zielinski J: Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis. Sarcoidosis 1993; 10: 56-61.
270. Milman N, Graudal N, Grode G, Munch E: No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J Intern Med 1994; 236: 285-290.
271. Selroos OB: Use of budesonide in the treatment of pulmonary sarcoidosis. Ann NY Acad Sci 1986; 465: 713-721.
272. Alberts C, van der Mark TW, Jansen HM: Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis Eur Respir J 1995; 8: 682-688.
273. Henderson CA, Ilchyshyn A, Curry AR: Laryngeal and cutaneous sarcoidosis treated with methotrexate. J R Soc Med 1994; 87: 632-633.
274. Israel HL: The treatment of sarcoidosis. Postgrad Med J 1970; 46: 537-540.
275. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG: Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995; 34: 642-644.
276. Lacher MJ: Spontaneous remission or response to methotrexate in sarcoidosis. Ann Intern Med 1968; 69: 1247-1248.
277. Lower EE, Baughman RP: The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990; 299: 153-157.
278. Lower EE, Baughman RP: Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155: 846-851.
279. Rajendran R, Theertham M, Salgia R, Muthuswamy P: Methotrexate in the treatment of cutaneous sarcoidosis. Sarcoidosis 1994; 11: S335-S338.
280. Webster GF, Razsi LK, Sanchez M, Shupack JL: Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 1991; 24: 451-154.
281. Gelwan MJ, Kellen RI, Burde RM, Kupersmith MJ: Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry 1988; 51: 1473-1480.
282. Sharma O, Hughes D, James D, Naish P: Immunosuppressive therapy with azathioprine in sarcoidosis. In Levinsky L, Macholoa F, Eds. Fifth International Conference on Sarcoidosis and Other Granulomatous Disorders. Universita Karlova, Prague. 1971; pp 635-637.
283. Hof D, Hof P, Gdofrey W: Long-term use of azathioprine as a steroid-sparing treatment for chronic sarcoidosis. Am J Respir Crit Care Med. 1996; 153: A870.
284. Pacheco Y, Marechal C, Marechal F, Biot N, Perrin Fayolle M: Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 1985; 2: 107-113.
285. Hughes GS, Jr, Kataria YP, O'Brien TF, Jr: Sarcoidosis presenting as biliary cirrhosis: treatment with chlorambucil. South Med J 1983; 76: 1440-1442.
286. Kataria YP: Chlorambucil in sarcoidosis. Chest 1980; 78: 36-43.
287. Demeter SL: Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest 1988; 94: 202-203.
288. Kwong T, Valderrama E, Paley C, Ilowite N: Systemic necrotizing vasculitis associated with childhood sarcoidosis. Semin Arthritis Rheum 1994; 23: 388-395.
289. Zuber M, Defer G, Cesaro P, Degos JD: Efficacy of cyclophosphamide in sarcoid radiculomyelitis [letter]. J Neurol Neurosurg Psychiatry 1992; 55: 166-167.
290. Lower EE, Broderick JP, Brott TG, Baughman RP: Diagnosis and management of neurological sarcoidosis [see comments]. Arch Intern Med 1997; 157: 1864-1868.
291. Fries JF, Williams CA, Ramey D, Bloch DA: The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993; 36: 297-306.
292. Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA: Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol 1991; 18: 188-194.
293. Willkens RF, Urowitz MB, Stablein DM et al: Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial [see comments]. Arthritis Rheum 1992; 35: 849-856.
294. Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, Selby PB: Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res 1995; 330: 115-181.
295. Ramsey-Goldman R, Mientus JM, Kutzer JE, Mulvihill JJ, Medsger TA, Jr.: Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 1993; 20: 1152-1157.
296. Bailin PL, Tindall JP, Roenigk HH, Jr, Hogan MD: Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis. JAMA 1975; 232: 359-362.
297. Nyfors A, Jensen H: Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study. Dermatologica 1983; 167: 260-261.
298. Rustin G, Rustin F, Dent J, Booth M, Salt S: No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med 1982; 308: 473-476.
299. Schnabel A, Richter C, Bauerfeind S, Gross WL: Bronchoalveolar lavage cell profile in methotrexate induced pneumonias. Thorax 1997; 52: 377-379.
300. Sostman HD, Matthay RA, Putman CE, Smith GJ: Methotrexate-induced pneumonias. Medicine 1976; 55: 371-388.
301. Tolman KG, Clegg DO, Lee RG, Ward JR: Methotrexate and the liver. J Rheumatol 1985; 12 Suppl 12: 29-34.
302. Kehinde EO, Petermann A, Morgan JD et al: Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994; 81: 985-986.
303. Ritters B, Grabensee B, Heering P: Malignancy under immunosuppressive therapy including cyclosporine. Transplant Proc 1994; 26: 2656-2657.
304. Taylor AE, Shuster S: Skin cancer after renal transplantation: the causal role of azathioprine. Acta Derm Venereol 1992; 72: 115-119.
305. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee. J Rheumatol 1991; 18: 809-814.
306. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA, Jr: Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987; 83: 1-9.
307. Talar-Williams C, Hijazi YM, Walther MM et al: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis [see comments]. Ann Intern Med 1996; 124: 477-184.
308. Travis LB, Curtis RE, Glimelius B et al.: Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995; 87: 524-530.
309. Morgan SL, Baggott JE, Vaughn WH et al: Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial [see comments]. Ann Intern Med 1994; 121: 833-841.
310. Ben Ari Z, Mehta A, Leonard L, Burroughs AK: Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. J Hepatol 1995; 23: 351-354.
311. Escousse A, Mousson C, Santona L, et al: Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study. Transplant Proc 1995; 27: 1739-1742.
312. Siltzbach LE, Teirstein AS: Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl 1964; 425: 302-308.
313. Adams JS, Diz MM, Sharma OP: Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989; 111: 437-438.
314. Association BT: Chloroquine in the treatment of sarcoidosis. Tubercle 1967; 47: 252-257.
315. Zic JA, Horowitz DH, Arzubiaga C, King TE, Jr.: Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 1991; 127: 1034-1040.
316. Quatraro A, Consoli G, Magno M et al: Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med 1990; 112: 678-681.
317. Adams JS, Sharma OP, Diz MM, Endres DB: Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 1990; 70: 1090-1095.
318. Ejaz AA, Zabaneh RI, Tiwari P, Nawab ZM, Leehey DJ, Ing TS: Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis. Nephrol Dial Transplant 1994; 9: 1492-1494.
319. Pia G, Pascalis L, Aresu G, Rosetti L, Ledda MA: Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 146-152.
320. Martinet Y, Pinkston P, Saltini C, Spurzem J, Muller-Quernheim J, Crystal RG: Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis 1988; 138: 1242-1248.
321. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G: The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992; 49: 1065-1072.
322. Ahmad K, Kim YH, Spitzer AR et al: Total nodal radiation in progressive sarcoidosis. Case report. Am J Clin Oncol 1992; 15: 311-313.
323. Cagnoni ML, Lombardi A, Cerinic MC, Dcdola GL, Pignone A: Melatonin for treatment of chronic refractory sarcoidosis [letter]. Lancet 1995; 346: 1229-1230.
324. Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S: Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 1995; 32: 866-869.
325. Zabel P, Entzian P, Dalhoff K, Schlaak M: Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155: 1665-1669.
326. Rizzato G, Montemurro L: Reversibility of exogenous corticosteroid-induced bone loss. Eur Respir J 1993; 6: 116-119.
327. Rizzato G, Fraioli P, Montemurro L: Long-term therapy with deflazacort in chronic sarcoidosis. Chest 1991; 99: 301-309.
328. 327a Rizzato G, Riboldi A, Imbimbo B, Torresin A, Milani S: The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis. Resp Med 1997; 91: 449-460.
329. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G: Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991; 49: 71-76.
330. Padilla ML, Schilero GJ, Teirstein AS: Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 16-22.
331. Martinez FJ, Orens JB, Deeb M, Brunsting LA, Flint A, Lynch JP, 3rd.: Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 1994; 106: 1597-1599.
332. Casavilla FA, Gordon R, Wright HI, Gavaler JS, Starzl TE, Van Thiel DH: Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993; 118: 865-866.